M. Steiger

2.5k citations

40 papers · 1.8k indexed · h-index 23

Impact in

Neurology top 1%
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Botulinum Toxin and Related Neurological Disorders
Physical Therapy, Sports Therapy and Rehabilitation top 1%
- Balance, Gait, and Falls Prevention

Papers in ⓘ

Neurology 27
- Parkinson's Disease Mechanisms and Treatments 22
- Neurological disorders and treatments 17
- Botulinum Toxin and Related Neurological Disorders 9
Family Practice 1

Co-authors: C. D. Marsden (7 shared papers)P. D. Thompson (2 shared papers)Brian L. Day (1 shared paper)Tim Anderson (3 shared papers)Susan H. Fox (5 shared papers)Nicholas Fletcher (5 shared papers)К. Ray Chaudhuri (3 shared papers)Philip D. Thompson (2 shared papers)
Journals: Journal of Neurology (6 papers)Movement Disorders (5 papers)Journal of Neurology Neurosurgery & Psychiatry (5 papers)Clinical Neuropharmacology (3 papers)Journal of the Royal Society of Medicine (3 papers)
Partner nations: United Kingdom United States Germany

In The Last Decade

M. Steiger

39 papers receiving 1.7k citations

Peers

Countries citing papers authored by M. Steiger

Since Specialization

Citations

This map shows the geographic impact of M. Steiger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Steiger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Steiger more than expected).

Fields of papers citing papers by M. Steiger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Steiger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Steiger. The network helps show where M. Steiger may publish in the future.

Co-authors

The 25 scholars most cited alongside M. Steiger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M. Steiger Line = papers co-authored together M. Steiger links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Effect of vision and stance width on human body motion when standing: implications for afferent control of lateral sway. The Journal of Physiology ·Brian L. Day, M. Steiger, P. D. Thompson, C. D. Marsden	1993	343
2	Rotigotine effects on early morning motor function and sleep in Parkinson's disease: A double‐blind, randomized, placebo‐controlled study (RECOVER) Movement Disorders ·Claudia Trenkwalder, Bryan Kies, Monika Rudzińska, Jennifer Fine, Janos Nikl, Krystyna Honczarenko, Péter Diószeghy, D. Hill, Tim Anderson, Vilho V. Myllylä, Jan Kassubek, M. Steiger, Marco Zucconi, Eduardo Tolosa, Werner Poewe, Erwin Surmann, John Whitesides, Babak Boroojerdi, К. Ray Chaudhuri, Type Diabetes TrialNet Study Group	2010	326
3	Levodopa‐carbidopa intestinal gel in advanced Parkinson's disease: Final 12‐month, open‐label results Movement Disorders ·Hubert H. Fernandez, David G. Standaert, Robert A. Hauser, Anthony E. Lang, Victor S.C. Fung, Fabian Klostermann, Mark Lew, Per Odin, M. Steiger, E Z Yakupov, Sylvain Chouinard, Oksana Suchowersky, Jordan Dubow, Coleen Hall, Krai Chatamra, Weining Robieson, Janet Benesh, Alberto J. Espay	2014	187
4	Botulinum Toxin Treatment of Spasmodic Torticollis Journal of the Royal Society of Medicine ·Tim Anderson, J. Rivest, Rick Stell, M. Steiger, Hart Cohen, Philip D. Thompson, C. D. Marsden	1992	85
5	A 10 year retrospective audit of long-term apomorphine use in Parkinson?s disease Journal of Neurology ·H. Tyne, Jan Parsons, Ann Sinnott, Susan H. Fox, Nicholas Fletcher, M. Steiger	2004	81
6	Using a smartphone-based self-management platform to support medication adherence and clinical consultation in Parkinson’s disease npj Parkinson s Disease ·Rashmi Lakshminarayana, Duolao Wang, David J. Burn, К. Ray Chaudhuri, Clare Galtrey, Natalie Valle Guzman, Bruce Hellman, Ben James, Suvankar Pal, Jon Stamford, M. Steiger, R. W. Stott, James Teo, Roger A. Barker, Emma Wang, Bastiaan R. Bloem, Martijn van der Eijk, Lynn Rochester, Adrian J. Williams	2017	77
7	Disordered axial movement in Parkinson's disease. Journal of Neurology Neurosurgery & Psychiatry ·M. Steiger, P. D. Thompson, C. D. Marsden	1996	71
8	Effectiveness of piracetam in cortical myoclonus Movement Disorders ·Peter Brown, M. Steiger, Philip D. Thompson, John C. Rothwell, B. L. Day, Maurice Salama, Tony Waegemans, C. D. Marsden	1993	60
9	Successful outcome of progressive multifocal leukoencephalopathy with cytarabine and interferon Annals of Neurology ·M. Steiger, Georgia Tarnesby, S.M. Gabe, J. McLaughlin, Anthony H.V. Schapira	1993	52
10	Non‐subtype‐selective opioid receptor antagonism in treatment of levodopa‐induced motor complications in Parkinson's disease Movement Disorders ·Susan H. Fox, Monty Silverdale, Mark Kellett, Rhys Davies, M. Steiger, Nicholas Fletcher, Alan R. Crossman, Jonathan M. Brotchie	2003	50
11	Use of the NeuroMate Stereotactic Robot in a Frameless Mode for Movement Disorder Surgery Stereotactic and Functional Neurosurgery ·T.R.K. Varma, Paul Eldridge, Alexander Förster, Susan H. Fox, Nicholas Fletcher, M. Steiger, P. Littlechild, Paul Byrne, A. Sinnott, K. Tyler, S. Flintham	2003	49
12	Double-blind study of the activity and tolerability of cabergoline versus placebo in parkinsonians with motor fluctuations Journal of Neurology ·M. Steiger, T. El-Debas, Tim Anderson, Leslie J. Findley, C. D. Marsden	1995	40
13	Modafinil for Parkinson’s disease fatigue Journal of Neurology ·H. Tyne, Joanne Taylor, Gus A. Baker, M. Steiger	2009	37
14	An 11-year retrospective experience of antibodies against the voltage-gated potassium channel (VGKC) complex from a tertiary neurological centre Journal of Neurology ·Saif Huda, Sui H. Wong, Philippa Pettingill, D. O’Connell, Angela Vincent, M. Steiger	2014	33
15	Risk of valvular heart disease associated with the use of dopamine agonists in Parkinson’s disease: a systematic review Journal of Neural Transmission ·M. Steiger, Wolfgang H. Jost, Francisco Grandas, Guy Van Camp	2009	29
16	Variability in Position of the Subthalamic Nucleus Targeted by Magnetic Resonance Imaging and Microelectrode Recordings as Compared to Atlas Co-Ordinates Stereotactic and Functional Neurosurgery ·P. Littlechild, T.R.K. Varma, Paul Eldridge, Susan H. Fox, A. Förster, Nick Fletcher, M. Steiger, Patricia Byrne, K. Tyler, S. Flintham	2003	28
17	Deep brain stimulation of the subthalamic nucleus: effectiveness in advanced Parkinson's disease patients previously reliant on apomorphine Journal of Neurology Neurosurgery & Psychiatry ·T.R.K. Varma, Susan H. Fox, Paul Eldridge, P. Littlechild, Patricia Byrne, A. Förster, Andrew Marshall, Heather Cameron, Kirsten McIver, Nicholas Fletcher, M. Steiger	2003	27
18	The Clinical Efficacy of Single Morning Doses of Levodopa Methyl Ester Clinical Neuropharmacology ·M. Steiger, Fabrizio Stocchi, L. Bramante, Stefano Ruggieri, N. Quinn	1992	26
19	Cyclosporin associated headache. Journal of Neurology Neurosurgery & Psychiatry ·M. Steiger, Tariq E. Farrah, Keith Rolles, Peter Harvey, Andrew K. Burroughs	1994	26
20	Smartphone- and internet-assisted self-management and adherence tools to manage Parkinson’s disease (SMART-PD): study protocol for a randomised controlled trial (v7; 15 August 2014) Trials ·(unknown), Rashmi Lakshminarayana, Duolao Wang, David J. Burn, К. Ray Chaudhuri, Gemma Cummins, Clare Galtrey, Bruce Hellman, Suvankar Pal, Jon Stamford, M. Steiger, Adrian J. Williams	2014	25

About M. Steiger

M. Steiger is a scholar working on Neurology, Family Practice, Psychiatry and Mental health, Cellular and Molecular Neuroscience and Rheumatology, having authored 40 papers that have together received 1.8k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (22 papers), Neurological disorders and treatments (17 papers), Botulinum Toxin and Related Neurological Disorders (9 papers), Restless Legs Syndrome Research (5 papers), Neuroscience and Neuropharmacology Research (4 papers), Autism Spectrum Disorder Research (3 papers), Epilepsy research and treatment (3 papers) and Glycogen Storage Diseases and Myoclonus (3 papers). The work is most often cited by research in Neurology (1.2k citations), Physical Therapy, Sports Therapy and Rehabilitation (302 citations), Psychiatry and Mental health (284 citations), Cellular and Molecular Neuroscience (293 citations) and Cognitive Neuroscience (290 citations). M. Steiger has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include C. D. Marsden, P. D. Thompson, Brian L. Day, Tim Anderson, Susan H. Fox, Nicholas Fletcher, К. Ray Chaudhuri, Philip D. Thompson, Type Diabetes TrialNet Study Group and Jennifer Fine. Their work appears in journals such as Journal of Neurology, Movement Disorders, Journal of Neurology Neurosurgery & Psychiatry, Clinical Neuropharmacology and Journal of the Royal Society of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact